In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
June 21st, 2011 | 21 | Yes |
None
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.86 | 7.91 | -31.85 | 2 | 3 | 1 | 39 | 275.331 | 3 | ↓ |
Mid Mid (pH 6-8) | 3.86 | 6.82 | -10.52 | 1 | 3 | 0 | 38 | 274.323 | 3 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
EGFR-1-E | Epidermal Growth Factor Receptor ErbB1 (cluster #1 Of 4), Eukaryotic | Eukaryotes | 590 | 0.42 | Binding ≤ 10μM |
IGF1R-1-E | Insulin-like Growth Factor 1 Receptor (cluster #1 Of 2), Eukaryotic | Eukaryotes | 370 | 0.43 | Binding ≤ 10μM |
VGFR2-1-E | Vascular Endothelial Growth Factor Receptor 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 470 | 0.42 | Binding ≤ 10μM |
VGFR3-1-E | Vascular Endothelial Growth Factor Receptor 3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1090 | 0.40 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
EGFR_HUMAN | P00533 | Epidermal Growth Factor Receptor ErbB1, Human | 590 | 0.42 | Binding ≤ 1μM |
IGF1R_HUMAN | P08069 | Insulin-like Growth Factor I Receptor, Human | 370 | 0.43 | Binding ≤ 1μM |
VGFR2_HUMAN | P35968 | Vascular Endothelial Growth Factor Receptor 2, Human | 470 | 0.42 | Binding ≤ 1μM |
EGFR_HUMAN | P00533 | Epidermal Growth Factor Receptor ErbB1, Human | 590 | 0.42 | Binding ≤ 10μM |
IGF1R_HUMAN | P08069 | Insulin-like Growth Factor I Receptor, Human | 370 | 0.43 | Binding ≤ 10μM |
VGFR2_HUMAN | P35968 | Vascular Endothelial Growth Factor Receptor 2, Human | 470 | 0.42 | Binding ≤ 10μM |
VGFR3_HUMAN | P35916 | Vascular Endothelial Growth Factor Receptor 3, Human | 1090 | 0.40 | Binding ≤ 10μM |
Description | Species |
---|---|
Constitutive PI3K/AKT Signaling in Cancer | |
EGFR downregulation | |
EGFR interacts with phospholipase C-gamma | |
EGFR Transactivation by Gastrin | |
EPHA-mediated growth cone collapse | |
GAB1 signalosome | |
GRB2 events in EGFR signaling | |
GRB2 events in ERBB2 signaling | |
Integrin cell surface interactions | |
IRS-related events triggered by IGF1R | |
Neurophilin interactions with VEGF and VEGFR | |
PI3K events in ERBB2 signaling | |
PIP3 activates AKT signaling | |
PLCG1 events in ERBB2 signaling | |
SHC-related events triggered by IGF1R | |
SHC1 events in EGFR signaling | |
SHC1 events in ERBB2 signaling | |
Signal transduction by L1 | |
Signaling by constitutively active EGFR | |
Signaling by EGFR | |
Signaling by ERBB2 | |
Signaling by ERBB4 | |
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | |
VEGF binds to VEGFR leading to receptor dimerization | |
VEGFA-VEGFR2 Pathway | |
VEGFR2 mediated cell proliferation |
No pre-computed analogs available. Try a structural similarity search.